Literature DB >> 8528083

Evidence from sequence information that the interleukin-1 receptor is a transmembrane GTPase.

T P Hopp1.   

Abstract

Evidence is presented that the cytoplasmic domain of the type I interleukin-1 receptor (IL-1R) may be a GTPase. This domain conserves segments of hydrophobic amino acids that suggest a structural relatedness to the ras protooncogene protein and other members of the GTPase superfamily, despite a lack of significant detectable sequence homology. When the hydrophobic segments of the IL-1R were aligned with similar segments of the GTPases, it became apparent that the IL-1Rs possess a number of conserved amino acids that represent plausible functional residues for base-specific binding of GTP, magnesium chelation, and phosphate ester hydrolysis. Furthermore, a segment of five contiguous residues were found that is identical between ras and the IL-1R, and which is positioned to form part of the guanine base binding pocket. If this model is correct, then the IL-1Rs possess a highly conserved effector protein binding region, but one that is entirely unrelated to the effector regions of other superfamily members. Therefore, if the IL-1R is indeed a GTPase, then its activation function may be directed to as-yet unrecognized effector target proteins, as part of a unique cellular signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528083      PMCID: PMC2143205          DOI: 10.1002/pro.5560040920

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

Review 1.  Protein surface analysis. Methods for identifying antigenic determinants and other interaction sites.

Authors:  T P Hopp
Journal:  J Immunol Methods       Date:  1986-04-03       Impact factor: 2.303

2.  Rapid and sensitive protein similarity searches.

Authors:  D J Lipman; W R Pearson
Journal:  Science       Date:  1985-03-22       Impact factor: 47.728

3.  The folding type of a protein is relevant to the amino acid composition.

Authors:  H Nakashima; K Nishikawa; T Ooi
Journal:  J Biochem       Date:  1986-01       Impact factor: 3.387

4.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

Review 5.  The immunoglobulin superfamily--domains for cell surface recognition.

Authors:  A F Williams; A N Barclay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

6.  Guanosine cyclic 3',5'-phosphate dependent protein kinase, a chimeric protein homologous with two separate protein families.

Authors:  K Takio; R D Wade; S B Smith; E G Krebs; K A Walsh; K Titani
Journal:  Biochemistry       Date:  1984-08-28       Impact factor: 3.162

7.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

8.  Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases.

Authors:  L Cohen; R Mohr; Y Y Chen; M Huang; R Kato; D Dorin; F Tamanoi; A Goga; D Afar; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  The 180-kD component of the neural cell adhesion molecule N-CAM is involved in cell-cell contacts and cytoskeleton-membrane interactions.

Authors:  G E Pollerberg; K Burridge; K E Krebs; S R Goodman; M Schachner
Journal:  Cell Tissue Res       Date:  1987-10       Impact factor: 5.249

10.  Sequences of the bovine and yeast ADP-ribosylation factor and comparison to other GTP-binding proteins.

Authors:  J L Sewell; R A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more
  1 in total

Review 1.  The role of interleukin-1 in general pathology.

Authors:  Naoe Kaneko; Mie Kurata; Toshihiro Yamamoto; Shinnosuke Morikawa; Junya Masumoto
Journal:  Inflamm Regen       Date:  2019-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.